StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co (BMY) stock

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3030% below fair value
$61.35−1.58 (-2.51%)

Close on Nov 17, 2026Market cap $125.41BP/E 13.6Yield 4.06%

Bristol Myers Squibb EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Bristol Myers Squibb's EV/EBITDA was 9.6× on Nov 11, 2026, against 8.9× a year earlier. Over the last 5 years it ranged from 6.1× to 51.3×, with a median of 9.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.6×−0.0
2025Dec 31, 20259.6×−21.3
2024Dec 31, 202430.9×+23.8
2023Dec 29, 20237.0×−2.6
2022Dec 30, 20229.6×−11.4
2021Dec 31, 202121.1×+9.5
2020Dec 31, 202011.6×−1.0
2019Dec 31, 201912.6×−1.6
2018Dec 31, 201814.3×−1.8
2017Dec 29, 201716.1×−4.1
2016Dec 30, 201620.2×−18.5
2015Dec 31, 201538.8×+14.4
2014Dec 31, 201424.4×−2.0
2013Dec 31, 201326.4×+12.1
2012Dec 31, 201214.3×–

More Bristol Myers Squibb figures

See a number that looks wrong?